TRIB
Trinity Biotech
TRIB
TRIB
19 hedge funds and large institutions have $5.95M invested in Trinity Biotech in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
86% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 7
Holders
19
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.67M | |
| 2 | +$52.4K | |
| 3 | +$27.8K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$10.6K |
| 5 |
GRP
Global Retirement Partners
San Rafael,
California
|
+$1.63K |
Top Sellers
| 1 | -$111K | |
| 2 | -$42.2K | |
| 3 | -$14.9K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$13.9K |
| 5 |
AC
Aristides Capital
Louisville,
Kentucky
|
-$12K |